Ann Camac

Statistics

Publications

Citations

233

H-Index

Active since

1990

Affiliations

Cleveland Clinic(Current)

Ann Camac is an author at Cleveland Clinic specializing in relapsing-remitting multiple sclerosis treatment, multiple sclerosis pharmacotherapy, and multiple sclerosis therapy.

Publications per year

1990–2017

Publications

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct

Ann Camac, Paul Greene, A. Khandji · Movement Disorders · 1990 · 55 citations

Medicine, Neurology, Neuroscience +14

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

Andrew Goodman, François Béthoux, Theodore R. Brown et al. · Multiple Sclerosis Journal · 2015 · 51 citations · Full text

Health Professions, Pharmacotherapy, Clinical Pharmacology +16

Lymphocyte subtypes in relapsing–remitting multiple sclerosis patients treated with dimethyl fumarate

Claudia Chaves, Rik Ganguly, C Ceresia et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2017 · 23 citations · Full text

Life Sciences, Hematology, Immunology +17

1–4 of 4